Carole L. Wallis - Concepedia

Author

Carole L. Wallis

Also Known As

Antonella Delmestri, C Wallis, C. L. Wallis, C. Wallis, C.L. Wallis, Carol L. Wallis, Carol Wallis, Carole L Wallis, Carole L. Wallis, Carole Lorraine Wallis

140

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Lancet Laboratories University of the Witwatersrand Amsterdam Institute for Global Health and Development Harvard University University of Washington

About

Carole L. Wallis is an author at Lancet Laboratories specializing in medicine, hiv, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	35	2.1K
2	Public Health	17	22	1.5K
3	Health Sciences	1	1	14
4	Natural Sciences	1	1	10
5	Social Sciences	1	1	38

Carole L. Wallis

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy Alison Halliday, Richard Bulbulia, Leo H. Bonati, The Lancet	2021	290
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study Raph L Hamers, Carole L. Wallis, Cissy Kityo, The Lancet Infectious Diseases EpidemiologyAntiretroviral TherapyHiv/aids CounsellingTreatment And PreventionHuman Retrovirus	2011	289
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study Raph L Hamers, Rob Schuurman, Kim Sigaloff, The Lancet Infectious Diseases Drug-resistance OutcomesHiv/aids CounsellingTreatment And PreventionHuman RetrovirusGlobal Health	2011	194
Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa Kim Sigaloff, Raph L Hamers, Carole L. Wallis, JAIDS Journal of Acquired Immune Deficiency Syndromes	2011	184
Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing, Clinical Infectious Diseases	2012	160
Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: A randomized, double blind placebo controlled trial Rafe Bundy, Ann F. Walker, Richard W. Middleton, Phytomedicine NutritionLipid DisorderCardiovascular DiseaseMedicineDouble Blind Placebo	2008	148
High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron Nigel Garrett, Asa Tapley, Jessica Andriesen, Viral DiagnosticsGeneticsImmunodeficienciesImmunologyPathology	2021	135
Transmitted HIV Type 1 Drug Resistance Among Individuals with Recent HIV Infection in East and Southern Africa Matt A. Price, Carole L. Wallis, Shabir Lakhi, AIDS Research and Human Retroviruses Sexual HealthTdrm TransmissionTreatment And PreventionNeurovirologyGlobal Health	2010	119
Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South Africa Carole L. Wallis, John W. Mellors, François Venter, JAIDS Journal of Acquired Immune Deficiency Syndromes	2010	105
Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection Linda‐Gail Bekker, Kevin Rebe, François Venter, Southern African Journal of HIV Medicine Southern AfricaContraceptive DiscontinuationPre-exposure ProphylaxisHealth ProtectionPreventive Medicine	2016	103

Page 1